Immune System News and Research

RSS

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

In a new study, researchers evidenced that the S2 subunit of SARS-CoV-2 spike (S) could be an integral component of a pan-coronavirus vaccine.

29 Jul 2022

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

In severe Covid-19 patients, the metabolism produces insufficient amounts of certain energy-rich compounds called ketone bodies. However, these energy carriers are needed by two important cell types in the immune system in order to fight the virus effectively.

28 Jul 2022

The bat-virus relationship examined

A new study examines the role of bats as reservoirs of several viruses and the factors that contribute to the emergence of these viruses.

28 Jul 2022

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Proteins called antibodies help the immune system find and attack foreign pathogens. Mini versions of antibodies, called nanobodies - natural compounds in the blood of animals such as llamas and sharks - are being studied to treat autoimmune diseases and cancer.

28 Jul 2022

Antibiotic exposure in early childhood linked to later development of asthma and allergies

Early exposure to antibiotics kills healthy bacteria in the digestive tract and can cause asthma and allergies, a new study demonstrates.

28 Jul 2022

The role of cellular or cytokine response and vaginal microbiome dysbiosis in the clearance, persistence, and recurrence of HPV infection

Researchers have reviewed the role of cytokine or cellular response and vaginal microbiome dysbiosis in the persistence, clearance, and recurrence of HPV infection

28 Jul 2022

Everything you need to know about Paxlovid — especially, should you take it?

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid.

28 Jul 2022

Gut bacterial 'super-producer' of histamine can cause pain flare-ups in some IBS patients

Researchers from McMaster University and Queen's University have discovered a gut bacterial 'super-producer' of histamine that can cause pain flare-ups in some patients with irritable bowel syndrome (IBS).

27 Jul 2022

Researchers unravel how one gut bacterium influences immunity

From immunity to metabolism to mental health, it seems like the gut microbiome has been linked to every aspect of human health and disease.

27 Jul 2022

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Researchers evaluate antibody titers after double COVID-19 vaccination among very elderly individuals over the age of 90 and a younger population.

27 Jul 2022

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Researchers at the Francis Crick Institute have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics.

27 Jul 2022

Study finds specific molecular barriers to SARS-CoV-2 replication in bat cells

Bat cells have specific molecular barriers to deal with SARS-CoV-2 replication, according to a study published in Journal of Virology —publication of the American Society of Microbiology— which includes the participation of Jordi Serra-Cobo, lecturer of the Faculty of Biology and the Biodiversity Research Institute (IRBio) of the University of Barcelona and expert on ecoepidemiological studies.

27 Jul 2022

Research can pave the way for early detection of biliary tract cancer

One of the deadliest forms of cancer is biliary tract cancer. Only one in three patients diagnosed with the disease is operable. The rest must settle for life-sustaining treatment.

27 Jul 2022

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation that Novavax's COVID-19 vaccine be used as another primary series option for adults ages 18 years and older.

26 Jul 2022

How COVID-19 affects the brain microvasculature

A recent study discusses the effects of COVID-19 on the brain microvascular system.

25 Jul 2022

Scientists investigate how interferons interact with SARS-CoV-2 variants

Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19.

25 Jul 2022

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

A new study reported the outcomes of a clinical trial evaluating the oral vaccine candidate against SARS-CoV-2 developed by Vaxart.

25 Jul 2022

SARS-CoV-2 hijacks tiny bridges that link infected cells with neurons to gain access to brain cells

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both during the acute phase of the disease and over the long term with "long COVID" syndrome.

25 Jul 2022

Scientists explore SARS-CoV-2 spike protein and platelet-activating factor

Researchers assessed the association between platelet-activating factor (PAF) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein.

25 Jul 2022

Immune System News and Research

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

The bat-virus relationship examined

Newly developed nanobody can get through tough brain cells and treat Parkinson’s disease

Antibiotic exposure in early childhood linked to later development of asthma and allergies

The role of cellular or cytokine response and vaginal microbiome dysbiosis in the clearance, persistence, and recurrence of HPV infection

Everything you need to know about Paxlovid — especially, should you take it?

Gut bacterial 'super-producer' of histamine can cause pain flare-ups in some IBS patients

Researchers unravel how one gut bacterium influences immunity

A comparison of SARS-CoV-2 antibody profiles in elderly and younger individuals

Specific area of SARS-CoV-2 spike protein found to be a promising target for pan-coronavirus vaccine

Study finds specific molecular barriers to SARS-CoV-2 replication in bat cells

Research can pave the way for early detection of biliary tract cancer

CDC: Novavax's COVID-19 vaccine can be used as another primary series option for adults

How COVID-19 affects the brain microvasculature

Scientists investigate how interferons interact with SARS-CoV-2 variants

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

SARS-CoV-2 hijacks tiny bridges that link infected cells with neurons to gain access to brain cells

Scientists explore SARS-CoV-2 spike protein and platelet-activating factor

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News